Last year's death of a four year-old in Boston, and concern over efficacy, have created a backlash about treating young children with atypical anti-psychotics. Sunday's Boston Globe report how child psychiatrists are lining up in the debate. In Mass., the number of children under the age of 18 who are receiving the most commonly prescribed drugs (Zyprexa, Risperdal, and Seroquel) increased 25 percent over a four year period ending in 2006.